ACY3 Antibody
-
中文名稱：ACY3兔多克隆抗體
-
貨號：CSB-PA001264GA01HU
-
規格：￥3,900
-
其他：
產品詳情
-
Uniprot No.：
-
基因名：ACY3
-
別名：AA3 antibody; ACY-3 antibody; acy3 antibody; ACY3_HUMAN antibody; Acylase III antibody; Aminoacylase 3 antibody; Aminoacylase III antibody; Aminoacylase-3 antibody; ASPA2 antibody; Aspartoacylase (aminoacylase) 3 antibody; Aspartoacylase 2 antibody; Aspartoacylase-2 antibody; AW107362 antibody; EC 3.5.1.- antibody; EC 3.5.1.15 antibody; HCBP1 antibody; Hepatitis C virus core binding protein 1 antibody; Hepatitis C virus core-binding protein 1 antibody
-
宿主：Rabbit
-
反應種屬：Human,Mouse,Rat
-
免疫原：Human ACY3
-
免疫原種屬：Homo sapiens (Human)
-
抗體亞型：IgG
-
純化方式：Antigen Affinity purified
-
濃度：It differs from different batches. Please contact us to confirm it.
-
保存緩沖液：PBS with 0.1% Sodium Azide, 50% Glycerol, pH 7.3. -20°C, Avoid freeze / thaw cycles.
-
產品提供形式：Liquid
-
應用范圍：ELISA,WB
-
Protocols：
-
儲存條件：Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.
-
貨期：Basically, we can dispatch the products out in 1-3 working days after receiving your orders. Delivery time maybe differs from different purchasing way or location, please kindly consult your local distributors for specific delivery time.
-
用途：For Research Use Only. Not for use in diagnostic or therapeutic procedures.
產品評價
相關產品
靶點詳情
-
功能：Plays an important role in deacetylating mercapturic acids in kidney proximal tubules. Also acts on N-acetyl-aromatic amino acids.
-
基因功能參考文獻：
- Suggest that ACY3 is an HCV core binding protein, which may play a role in the development of HCV-associated diseases. PMID: 19486448
-
亞細胞定位：Apical cell membrane; Peripheral membrane protein. Cytoplasm. Note=Predominantly localized in the apical membrane of cells in the S1 segment. In the proximal straight tubules (S2 and S3 segments) is expressed diffusely throughout the cytoplasm.
-
蛋白家族：AspA/AstE family, Aspartoacylase subfamily
-
數據庫鏈接：
Most popular with customers
-
-
YWHAB Recombinant Monoclonal Antibody
Applications: ELISA, WB, IHC, IF, FC
Species Reactivity: Human, Mouse, Rat
-
-
-
-
-
-
